MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Government: International
North America
United States of America
*Government: U.S. Federal
Government: U.S. States & Territories
Government: States (U.S.)
Missouri
Industry: Missouri
VaxNewMo
Attachments
Home - VaxNewMo
Parents
*BioSTL_CDM (Center for Defense Medicine)
BioSTL_Center for National Pandemic Resiliency through Bioscience
Industry: Missouri
Portfolio Companies: BioGenerator
Children
Co-founder, Dr. Mario Feldman, VaxNewMo (2021)
Developing novel anti-bacterial bioconjugate vaccines recombinantly using E. coli as a host – no longer dependent on conventional complex synthetic chemistry for conjugate vaccine production.
Dr. Christian Harding. co-founder and CEO of VaxNewMo (2021)
Founded 2016
Next generation Pneumococcal bioconjugate vaccine, (2) multivalent Klebsiella pneumoniae bioconjugate vaccine, and (3) a comprehensive Group B Streptococcus bioconjugate vaccine.
VaxNewMo is an early stage biotechnological company developing next-generation conjugate vaccines against infectious diseases using our proprietary in vivo conjugating technology